An Interesting Drug for Type 2: TAK-875

Proper greatergood_ctg_belowtitle

EmaxHealth Health News

By Kathleen Blanchard RN for

Researchers have developed a novel way to control Type 2 diabetes with the oral drug TAK-875. The drug targets cells in the pancreas that stimulate the production of insulin, without the risk of hypoglycemia. Compared to the popular diabetes drug, glimepiride, patients studied had less risk of developing low blood sugar. If levels are normal, TAK-875 has no effect.

Results of a Phase 2 clinical trial, published in the journal Lancet, found the drug worked well to lower HbA1C levels in patients with Type 2 diabetes who failed to keep the disease under control with diet, exercise or the diabetes drug metformin.

“LIKE” EmaxHealth news on Facebook to receive links to important articles in your Facebook feed!

Here's Why Your Diabetes Puts You at Greater Risk for a Broken Bone: Click “Next” below!

The Diabetes Site is a place where people can come together to help those whose lives have been affected by diabetes. In addition to sharing inspiring stories, shopping for the cause, and signing petitions, visitors can take just a moment each day to c lick on the red button to provide much-needed support for diabetes research. Visit The Diabetes Site and click today - it's free!
Proper greatergood_ctg_belowcontent